Quantum Computing Inc. Applies Optimization and AI to XPro Research

Quantum Computing Inc. and INmune Bio, Inc. will use quantum optimization and artificial intelligence to analyze data on XPro, an investigational drug candidate, seeking patient biomarkers and possible new uses for the treatment. The Stage 1 engagement will combine Quantum Computing Inc.’s Dirac-3S quantum optimization machine with AI and conventional analytics. The work will draw on INmune Bio’s preclinical research, data from four clinical trials and publicly available biomedical datasets. The companies plan to compare quantum methods with standard statistical and machine-learning approaches to assess which methods fit different parts of the analysis.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.